EHMT2 and small cell lung carcinoma: EHMT2 was demonstrated to promote SCLC transformation from LUAD lines in vitro, and inhibition of EHMT2 could reverse this phenotype [48], suggesting it may have a role in maintenance of the NE lineage, although this does not preclude an earlier role as well.